The cold sore virus takes over its host’s transcription machinery to replicate itself. Inhibiting a host enzyme can halt ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Raipur: The state viral research and diagnostic laboratory (VRDL) at the All India Institute of Medical Sciences (AIIMS), ...

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

A 56-year-old woman with a history of relapsed/refractory IgG kappa multiple myeloma presented with a 3-day history of right ...

Assembly Biosciences ( NASDAQ: ASMB) reported promising results from an early stage study of its experimental candidate, ...

Two UAMS researchers have received $3.42 million in grant money from the National Institutes of Health to study a virus ...

Growing research shows common herpes viruses may raise dementia risk, challenging previous skepticism and opening new paths ...

A striking breakthrough in cancer therapy has emerged from an unexpected source: the common herpes simplex virus. A new ...

Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase inhibitor candidates – ...